Mahmut Gümüş (Mahmut Gumus)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 18

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Acta oncologica (Stockholm, Sweden)

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

Istanbul Medeniyet University

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Istanbul Medeniyet University Sep 01 2006

Turkey

Professor :: Medical Oncology

Publications

Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II study to determine the anti-tumor activity and safety of simlukafusp alfa (FAP-IL2v) combined with atezolizumab in esophageal cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Akihito Kawazoe, Rui-Hua Xu, Pilar García Alfonso, Maria Passhak, Hao-Wei Teng, Ardaman Shergill, Mahmut Gümüş, Camilla Qvortrup, Sebastian Stinzing, Kathryn Towns, Tae Won Kim, Kai-Keen Shiu, Juan Cundom, Sumitra Ananda, Andrey Lebedinets, Rong Fu, Rishi Jain, David Adelberg, Volker Heinemann, Takayuki Yoshino, Elena Elez Fernandez, null null
Lenvatinib Plus Pembrolizumab Versus Standard of Care for Previously Treated Metastatic Colorectal Cancer: Final Analysis of the Randomized, Open-Label, Phase III LEAP-017 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (24) (2024)
Hans Prenen, Sanjeev Deva, Bhumsuk Keam, Colin R Lindsay, Iwona Lugowska, James Chih-Hsin Yang, Federico Longo, Maria J de Miguel Luken, Mariano Ponz-Sarvisé, Myung-Ju Ahn, Mahmut Gümüş, Stephane Champiat, Antoine Italiano, Sebastien Salas, Ruth Perets, Cagatay Arslan, Byoung Chul Cho, Stefan Evers, Christophe Boetsch, Daniel Marbach, David Dejardin, Nassim Sleiman, Caroline Ardeshir, Muriel Richard, Jehad Charo, Anton Kraxner, Nino Keshelava, Volker Teichgräber, Victor Moreno
Phase II Study to Determine the Antitumor Activity and Safety of Simlukafusp Alfa (FAP-IL2v) Combined with Atezolizumab in Esophageal Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (14) (2024)
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Çakar, Abdallah T M Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gümüş, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study. Acta oncologica (Stockholm, Sweden) (2023)
Bradley J Monk, Nicoletta Colombo, Krishnansu S Tewari, Coraline Dubot, M Valeria Caceres, Kosei Hasegawa, Ronnie Shapira-Frommer, Pamela Salman, Eduardo Yañez, Mahmut Gümüş, Mivael Olivera, Vanessa Samouëlian, Vincent Castonguay, Alexander Arkhipov, Cumhur Tekin, Kan Li, Stephen M Keefe, Domenica Lorusso, null null
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Çakar, Abdallah T M Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gümüş, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study. Acta oncologica (Stockholm, Sweden) (2023)
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Çakar, Abdallah T M Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gümüş, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study. Acta oncologica (Stockholm, Sweden) (2023)
Ahmet Bilici, Omer Fatih Olmez, Muhammed Ali Kaplan, Berna Oksuzoglu, Ahmet Sezer, Nuri Karadurmus, Erdem Cubukcu, Mehmet Ali Nahit Sendur, Sercan Aksoy, Dilek Erdem, Gul Basaran, Burcu Çakar, Abdallah T M Shbair, Cagatay Arslan, Ahmet Taner Sumbul, Sema Sezgin Goksu, Ibrahim Karadag, Irfan Cicin, Mahmut Gümüş, Fatih Selcukbiricik, Hakan Harputluoglu, Umut Demirci
Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study. Acta oncologica (Stockholm, Sweden) (2023)
Silvia Novello, Dariusz Mirosław Kowalski, Alexander Luft, Mahmut Gümüş, David Vicente, Julien Mazieres, Jerónimo Rafael Rodríguez-Cid, Ali Tafreshi, Ying Cheng, Ki Hyeong Lee, Alexander Golf, Shunichi Sugawara, Andrew G Robinson, Balazs Halmos, Erin Jensen, Paul Schwarzenberger, M Catherine Pietanza, Luis G Paz-Ares
Pembrolizumab Plus Chemotherapy in Squamous Non-Small-Cell Lung Cancer: 5-Year Update of the Phase III KEYNOTE-407 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Thierry André, Filippo Pietrantonio, Antonio Avallone, Mahmut Gümüş, Lucjan Wyrwicz, Jong Gwang Kim, Suayib Yalcin, Mariusz Kwiatkowski, Sara Lonardi, Jakub Zolnierek, Amos Odeleye-Ajakaye, Pierre Leconte, David Fogelman, Tae Won Kim
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer. Future oncology (London, England) (2023)
Ozgecan Dulgar, Bala Başak Öven, Muhammet Mustafa Atcı, Rukiye Arıkan, Seval Ay, Murat Ayhan, Oğuzhan Selvi, Deniz Tataroğlu Özyükseler, Ertuğrul Bayram, Erkan Özcan, Ayse Irem Yasin, Mahmut Gümüş
Is the benefit of using adjuvant capecitabine in patients with residual triple-negative breast cancer related to pathological response to neoadjuvant chemotherapy? Expert review of anticancer therapy 22 (7) (2022)
Seval Ay, Muhammet Mustafa Atcı, Rukiye Arıkan, Ozgecan Dulgar, Deniz Tataroğlu Özyükseler, Nail Paksoy, Izzet Dogan, Buğra Öztosun, Didem Taştekin, Bala Başak Öven, Mahmut Gümüş
FOLFIRINOX versus gemcitabine plus nab-paclitaxel as the first-line chemotherapy in metastatic pancreatic cancer. Journal of chemotherapy (Florence, Italy) 34 (7) (2022)
Mahmut Gümüş, Chieh-I Chen, Cristina Ivanescu, Saadettin Kilickap, Igor Bondarenko, Mustafa Özgüroğlu, Miranda Gogishvili, Haci M Turk, Irfan Cicin, James Harnett, Vera Mastey, Ulrike Naumann, Matthew Reaney, Gerasimos Konidaris, Medha Sasane, Keri J S Brady, Siyu Li, Giuseppe Gullo, Petra Rietschel, Ahmet Sezer
Patient-reported outcomes with cemiplimab monotherapy for first-line treatment of advanced non-small cell lung cancer with PD-L1 of ≥50%: The EMPOWER-Lung 1 study. Cancer (2022)
Muhammet Mustafa Atcı, Caglayan Geredeli, Seval Ay, Abdullah Sakin, Biray Ertürk, Şaban Seçmeler, Serdar Arıcı, Ruhper Çekin, Nurgül Yaşar, Orçun Can, Sener Cihan, Mahmut Gümüş
Clinical and Pathological Characteristics of Patients with High-Risk Breast Cancer Based on BRCA Mutation Profiles: A Retrospective Study. European journal of breast health 17 (2) (2021)
Özlem Ercelep, Deniz Tataroğlu Özyükseler, Melike Ozcelik, Heves Surmeli, Mustafa Değirmenci, Mevlüde İnanç, Mehmet Aliustaoğlu, Mahmut Gümüş
Efficacy and safety of bevacizumab in Turkish patients with metastatic and recurrent cervical cancer. Turkish journal of obstetrics and gynecology 17 (2) (2020)

Mahmut Gümüş.css-eqlu8i{font-size:small;padding-left:4px;} (Mahmut Gumus)

Publication Activity (10 Years)

Top Topics

Top Venues

Mahmut Gümüş (Mahmut Gumus)